Drug profile · INN
parsaclisib
PARSACLISIB INCYTE BIOSCIENCES DISTRIBUTION B.V.
parsaclisib (PARSACLISIB INCYTE BIOSCIENCES DISTRIBUTION B.V.) is a pi3-kinase p110-delta subunit inhibitor.
EMA: application withdrawn Antineoplastic and immunomodulating agents (L01) L01EM04
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — parsaclisib
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
parsaclisib (PARSACLISIB INCYTE BIOSCIENCES DISTRIBUTION B.V.) is a pi3-kinase p110-delta subunit inhibitor.
Key facts
INN parsaclisib
Brand PARSACLISIB INCYTE BIOSCIENCES DISTRIBUTION B.V.
Mechanism PI3-kinase p110-delta subunit inhibitor
Target Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01EM04
Mechanism of action
PI3-kinase p110-delta subunit inhibitor
Primary target: Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is parsaclisib?
parsaclisib (PARSACLISIB INCYTE BIOSCIENCES DISTRIBUTION B.V.) is a pi3-kinase p110-delta subunit inhibitor.
What is the brand name for parsaclisib?
PARSACLISIB INCYTE BIOSCIENCES DISTRIBUTION B.V. is a marketed brand name for parsaclisib. Check FDA Drugs@FDA for the current US label holder and prescribing information.